Lex Fridman Podcast
Lex Fridman Podcast

Sep 17, 2026 · 3h 44m

Psychiatry confronts its history of certainty and harm

#502 – Psychiatry, Insane Asylums, Mental Illness, ECT, Lobotomies, Freud & Jung

The episode asks how a field with an uncertain evidence base can treat severe suffering without repeating the institutional and commercial abuses of its past.

3 key takeaways
  1. 1Psychiatric diagnoses organize care but remain imperfect classifications rather than definitive explanations of mental illness.
  2. 2Lobotomies, coma therapies, and early ECT reveal how institutional authority and weak evidence enabled dangerous experimentation.
  3. 3A more credible future combines cautious medication with therapy, family and community support, compassionate care, and better policy.

Don't miss

Scull’s account of lobotomy and Walter Freeman’s traveling transorbital demonstrations crystallizes how institutional enthusiasm turned irreversible harm into apparent therapeutic progress.

The brief

Historian Andrew Scull traces psychiatry’s rise from asylum care and psychoanalysis to modern diagnostic manuals, drugs, psychotherapy, and ECT—while questioning the authority behind each era.

The DSM offers a shared language for mental disorders, but its revisions cannot resolve whether categories reflect underlying diseases or shifting social, clinical, and institutional judgments.

Asylums began as projects of therapeutic rescue before becoming custodial institutions; later lobotomies, insulin comas, fever treatments, and early ECT exposed the danger of confident intervention without strong evidence.

Modern treatments are not dismissed wholesale: ECT can help severe depression, antipsychotics help some symptoms for some patients, and CBT offers a more testable therapeutic model.

Scull’s broader prescription is deliberately modest: combine careful medication with evidence-based therapy, family and community support, compassionate practitioners, and public policy that treats mental illness as social as well as medical.

What was said on this episode

49 statements · 13 positive · 26 negative · 3 mixed · 7 neutral

  1. Andrew T. Scullon Modern psychiatric treatmentsNegative10:57

    Psychiatry currently offers symptomatic treatments rather than cures.

    What we have available to us are symptomatic treatments, not cures.

    Listen at 10:57

  2. Andrew T. Scullon Trauma-focused PTSD treatmentNegative12:07

    Trauma confrontation during PTSD treatment can worsen symptoms for many patients.

    for many patients, it actually makes things worse.

    Listen at 12:07

  3. Andrew T. Scullon Antipsychotics and antidepressantsNegative12:27

    Antipsychotics and antidepressants are partially effective and fail for many patients.

    they're at best partially effective and they don't work for a significant fraction of patients who are given them.

    Listen at 12:27

  4. Andrew T. Scullon DSM-IIINegative14:00

    DSM-III was created because psychiatrists showed poor diagnostic agreement.

    that diagnostic system came into being because psychiatrists had a very hard time agreeing with one another about what was wrong with somebody.

    Listen at 14:00

  5. Andrew T. Scullon DSM diagnostic categoriesNegative17:25

    Reliable DSM diagnoses may not validly represent underlying psychiatric reality.

    that conclusion may or may not reflect the underlying reality of things

    Listen at 17:25

  6. Andrew T. Scullon NIMH psychiatric research fundingNegative20:04

    NIMH-funded neuroscience and genetics research produced no improvement for mentally ill people.

    after spending $20 billion, the lot of the mentally ill has improved not one bit

    Listen at 20:04

  7. Andrew T. Scullon NIMHNeutral20:55

    NIMH increasingly treated mental illness as purely brain disease.

    NIMH increasingly focused on the idea that mental illness was purely a brain disease.

    Listen at 20:55

  8. Andrew T. Scullon Social factors in mental illnessNeutral23:13

    Social factors play an important role in developing mental illness.

    there's abundant evidence from epidemiology that social factors play an important role, in the development of mental illness.

    Listen at 23:13

  9. Andrew T. Scullon DSM psychiatric categoriesNegative26:47

    Traditional psychiatric categories are increasingly viewed as unstable or potentially misleading.

    the categories that we have all become familiar with, that we've been told are real diseases like bipolar disorder, schizophrenia, major depression, are beginning to falter.

    Listen at 26:47

  10. Andrew T. Scullon Community mental-health careNegative37:10

    Community care failed to provide adequate substitutes for psychiatric asylums.

    community care is a shell game without a pea.

    Listen at 37:10

  11. Andrew T. Scullon Early psychiatric asylumsPositive45:18

    Early asylums helped some patients and enabled some recoveries.

    I do believe the early asylums actually did good work and that some patients did very well and recovered as a result of their stays.

    Listen at 45:18

  12. Andrew T. Scullon LobotomyNegative57:46

    The scientific basis of lobotomy was weak.

    the science behind it was shaky

    Listen at 57:46

  13. Andrew T. Scullon Malaria therapy for general paralysis of the insaneNegative1:08:57

    Claims about malarial treatment curing syphilitic insanity were greatly exaggerated.

    those claims were wildly exaggerated, but they were widely accepted.

    Listen at 1:08:57

  14. Andrew T. Scullon Insulin coma therapyNegative1:25:39

    Insulin coma therapy failed controlled clinical testing.

    when they were subjected to a controlled trial, they failed it.

    Listen at 1:25:39

  15. Andrew T. Scullon Electroconvulsive therapyPositive1:32:05

    ECT appears effective for severe, especially suicidal, depression.

    it seems to work in cases of depression, suicidal depression particularly.

    Listen at 1:32:05

  16. Andrew T. Scullon Modified ECTPositive1:34:47

    Muscle relaxants largely eliminated fractures associated with ECT.

    you did eliminate the fractures.

    Listen at 1:34:47

  17. Andrew T. Scullon Electroconvulsive therapyMixed1:35:20

    ECT temporarily alleviates psychiatric symptoms rather than curing them.

    it temporarily alleviates the symptoms

    Listen at 1:35:20

  18. Andrew T. Scullon Schizophrenia geneticsNeutral1:42:34

    Three hundred genetic variants explain about ten percent of schizophrenia susceptibility.

    if we use 300 small variations in the genome, we can account for about 10% of schizophrenia.

    Listen at 1:42:34

  19. Andrew T. Scullon Schizophrenia and bipolar disorderNegative1:43:40

    Some psychiatrists predict schizophrenia and bipolar disorder may be abandoned as distinct entities.

    there's no such thing as schizophrenia, there's no such thing as bipolar disorder

    Listen at 1:43:40

  20. Andrew T. Scullon Ketamine and psychedelics for depressionNegative1:45:17

    Ketamine and psychedelics are being promoted as miracle cures for depression.

    I see ketamine and psychedelics being propounded as a miracle cure for depression

    Listen at 1:45:17

  21. Andrew T. Scullon Ketamine and psychedelics for depressionNegative1:45:25

    Evidence supporting ketamine and psychedelics as depression cures is very weak.

    the evidence for that is enormously weak

    Listen at 1:45:25

  22. Andrew T. Scullon Negative scientific findingsPositive1:47:40

    Negative findings are important for scientific progress.

    negative findings are very important in science.

    Listen at 1:47:40

  23. Andrew T. Scullon ECT in mental hospitalsNegative1:57:10

    ECT was used as a disciplinary tool in many mid-century mental hospitals.

    ECT was used in the '50s and '60s as a tool of discipline in the hospitals.

    Listen at 1:57:10

  24. Andrew T. Scullon Electroconvulsive therapyPositive2:01:03

    Recent controlled trials provide enough evidence that ECT benefits some patients.

    there's enough evidence now that it's hard to say this never works.

    Listen at 2:01:03

  25. Andrew T. Scullon Combat-related psychological breakdownNegative2:44:50

    Up to one-quarter of soldiers experienced psychological breakdown in combat conditions.

    In combat conditions, as much as 25% of the soldiers broke down.

    Listen at 2:44:50

  26. CBT-style therapies can be standardized, reproduced, and empirically tested.

    these therapies could be packaged. They could be reproduced. They could be tested to see whether they worked.

    Listen at 2:50:37

  27. Andrew T. Scullon CBT for mild depressionPositive2:54:58

    CBT may outperform antidepressants for milder depression with fewer side effects.

    for the milder forms depression, I think CBT works better than the drugs without some of the side effects that the drugs have.

    Listen at 2:54:58

  28. CBT substantially improves outcomes for some patients.

    for some patients, this really does seem to improve things quite a lot.

    Listen at 2:56:22

  29. Andrew T. Scullon PsychopharmacologyNeutral2:58:16

    Psychopharmacology emerged accidentally rather than from planned psychiatric drug development.

    the idea that a drug might be used to actually attack the underlying problem, it emerged by accident

    Listen at 2:58:16

  30. Andrew T. Scullon Antipsychotic drugsPositive3:07:45

    Antipsychotics reduce agitation, delusions, and hallucinations for many patients.

    they reduce the agitation, they reduce the delusions and the hallucinations

    Listen at 3:07:45

  31. Andrew T. Scullon Antipsychotic drugsNegative3:09:19

    Antipsychotics have limited effect on schizophrenia’s negative symptoms.

    the negative side of things, not so much or not at all.

    Listen at 3:09:19

  32. Andrew T. Scullon Antipsychotic drugsNegative3:09:33

    A significant share of psychotic patients do not respond to antipsychotic drugs.

    a significant number of psychotic patients are non-drug responders

    Listen at 3:09:33

  33. Andrew T. Scullon Psychiatric drug trialsNegative3:15:04

    Drug companies controlled much psychiatric trial data and selectively released results.

    the studies were funded by the drug companies who owned the data and controlled the data and only released what they chose to release

    Listen at 3:15:04

  34. Andrew T. Scullon FDA psychiatric drug approvalNegative3:15:31

    FDA approval could follow two successful trials despite many failed trials.

    if you had 2 that worked, that was enough.

    Listen at 3:15:31

  35. Andrew T. Scullon CATIE antipsychotic trialNegative3:16:42

    Sixty-seven to eighty-two percent of CATIE participants discontinued treatment.

    Between 67 and 82% of the patients, depending on which drug they were on, dropped out of the trial

    Listen at 3:16:42

  36. Andrew T. Scullon Second-generation antipsychoticsNegative3:17:14

    Second-generation antipsychotics commonly cause substantial weight gain and metabolic risks.

    If you take these pills, you will gain, in most cases, a of weight. 10, 20, 30, 40 pounds, 50 pounds.

    Listen at 3:17:14

  37. Andrew T. Scullon Personalized psychiatric prescribingNegative3:18:45

    Clinicians lack biological markers predicting individual psychiatric drug response.

    we have no biological markers at the moment that would tell us.

    Listen at 3:18:45

  38. Andrew T. Scullon Depression diagnosisNeutral3:21:49

    Depression is now an extremely common psychiatric diagnosis.

    depression is the common cold of psychiatry.

    Listen at 3:21:49

  39. Andrew T. Scullon Autism diagnosisNeutral3:24:04

    Autism diagnosis growth is driven more by loosened criteria than increased underlying prevalence.

    the huge increase in the number of diagnoses of autism is more driven by the fact he loosened the criteria for the diagnosis than it is because there are more actual cases.

    Listen at 3:24:04

  40. Andrew T. Scullon AntidepressantsMixed3:29:11

    Antidepressants consistently beat placebo statistically but not always clinically.

    Every time you do a controlled study of these antidepressants, they beat placebo in a statistically significant margin, but not necessarily in a clinically significant margin.

    Listen at 3:29:11

  41. Andrew T. Scullon AntidepressantsNegative3:30:08

    Antidepressants provide only marginal benefit over placebo for most patients.

    for most patients, antidepressants are marginally better than placebo

    Listen at 3:30:08

  42. Andrew T. Scullon AntidepressantsNegative3:30:44

    Many antidepressant users experience complete loss of libido.

    lots of patients find a complete loss of libido

    Listen at 3:30:44

  43. Andrew T. Scullon NICE depression guidancePositive3:31:34

    NICE recommends CBT before antidepressant medication in relevant cases.

    NICE in England are saying use CBT as the first line, not drugs.

    Listen at 3:31:34

  44. Andrew T. Scullon Antidepressants for depressionNegative3:32:12

    At least forty percent of depressed patients may not respond to antidepressants.

    we're talking 40 or north of 40% who aren't responding.

    Listen at 3:32:12

  45. Andrew T. Scullon Medication for severe mental illnessPositive3:33:34

    People with severe psychiatric suffering should probably try medication.

    you probably need to try the drugs because the suffering is very intense

    Listen at 3:33:34

  46. Andrew T. Scullon Psychiatric research prioritiesPositive3:33:49

    Psychiatric research should expand beyond drugs, neuroscience, and genetics.

    psychiatric research needs to broaden.

    Listen at 3:33:49

  47. Andrew T. Scullon Social support and mental healthPositive3:36:57

    Social support and interaction substantially benefit mental health.

    helping people as much as we can with social supports and social interaction is tremendously important to people's mental health.

    Listen at 3:36:57

  48. Andrew T. Scullon Major mental illnessesNeutral3:37:31

    Major mental illnesses likely have biological components.

    I would be astonished if the major forms of mental illness didn't have a biological component to them.

    Listen at 3:37:31

  49. Andrew T. Scullon Psychiatric medicationMixed3:40:46

    Medication can help but cannot solve the full problem of mental illness.

    a less reliance on something as simple as giving people pills because that can help, but it's clearly not going to be the solution to the whole thing.

    Listen at 3:40:46

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Books & mentions

Listen to the full episode and explore every guest, topic, and moment on PodLume.

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

Psychiatry confronts its history of certainty and harm | PodLume